Thomas Brunner

10.1k total citations · 2 hit papers
170 papers, 5.9k citations indexed

About

Thomas Brunner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Thomas Brunner has authored 170 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Oncology, 63 papers in Pulmonary and Respiratory Medicine and 44 papers in Surgery. Recurrent topics in Thomas Brunner's work include Pancreatic and Hepatic Oncology Research (60 papers), Advanced Radiotherapy Techniques (24 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Thomas Brunner is often cited by papers focused on Pancreatic and Hepatic Oncology Research (60 papers), Advanced Radiotherapy Techniques (24 papers) and Hepatocellular Carcinoma Treatment and Prognosis (23 papers). Thomas Brunner collaborates with scholars based in Germany, United Kingdom and Austria. Thomas Brunner's co-authors include Ruth J. Muschel, W. Gillies McKenna, Serena Lunardi, Anca-Ligia Grosu, Gerhard G. Grabenbauer, Rolf Sauer, Osama Al‐Assar, Emmanouil Fokas, Tine S. Mantoni and Eric J. Bernhard and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Thomas Brunner

165 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams

2019 219 citations Nicolaus Andratschke, Oliver Blanck et al. Strahlentherapie und Onkologie profile →
Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).

2024 37 citations Jens Hoeppner, Thomas Brunner et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Thomas Brunner

Since Specialization

Citations

This map shows the geographic impact of Thomas Brunner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Brunner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Brunner more than expected).

Fields of papers citing papers by Thomas Brunner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Brunner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Brunner. The network helps show where Thomas Brunner may publish in the future.

Co-authorship network of co-authors of Thomas Brunner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Brunner. A scholar is included among the top collaborators of Thomas Brunner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Brunner. Thomas Brunner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review 2026 ·Clinical and Translational Radiation Oncology ·(unknown), (unknown), (unknown), Thomas Brunner, (unknown), (unknown), Elke Firat, (unknown), Julian Philipp Layer, (unknown), (unknown), Gabriele Niedermann, (unknown), Falk Röder, (unknown), (unknown), (unknown), (unknown), (unknown), Eleni Gkika	0
2	Stereotactic radiotherapy for spinal and non-spinal bone metastases: a patterns-of-care analysis in German-speaking countries as part of a project of the interdisciplinary Radiosurgery and Stereotactic Radiotherapy Working Group of the DEGRO/DGMP 2025 ·Strahlentherapie und Onkologie ·(unknown), (unknown), (unknown), Alexander Rühle, (unknown), Clemens Seidel, Eleni Gkika, David Krug, (unknown), Christos Moustakis, Thomas Brunner, (unknown), (unknown)	1
3	Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial). breakdown → 2024 ·Journal of Clinical Oncology ·Jens Hoeppner, Thomas Brunner, Florian Lordick, Claudia Schmoor, Birte Kulemann, Ulf P. Neumann, Gunnar Folprecht, Tobias Keck, Frank Benedix, (unknown), (unknown), Christiane J. Bruns, Johan Friso Lock, Benedikt Reichert, Michael Ghadimi, Kai Wille, Ines Gockel, Jakob R. Izbicki, Stefan Utzolino, Peter Grimminger	37
4	944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial 2023 ·Annals of Oncology ·Bálint Tamaskovics, Markus Hecht, Philipp Schubert, Axel Kallies, Thomas Illmer, J. Radke, Oliver Koelbl, Felix Steger, Thomas Brunner, Claus Rödel, Maximilian Fleischmann, Anke Reinacher‐Schick, (unknown), Patrick Melchior, Günther Klautke, (unknown), Udo S. Gaipl, Jan Haussmann, Wilfried Budach, Rainer Fietkau	1
5	Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options 2020 ·Best Practice & Research Clinical Gastroenterology ·(unknown), Maciej Powerski, Dörthe Jechorek, Thomas Brunner, Jochen Weigt, Marino Venerito	9
6	Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma 2018 ·Radiotherapy and Oncology ·Thomas Brunner, Oliver Blanck, Victor Lewitzki, (unknown), Felix Momm, Oliver Riesterer, Marciana Nona Duma, Stefan De Wachter, Wolfgang W. Baus, S. Gerum, Matthias Gückenberger, Eleni Gkika	33
7	Repeated SBRT for in- and out-of-field recurrences in the liver 2018 ·Strahlentherapie und Onkologie ·Eleni Gkika, Iosif Strouthos, Simon Kirste, Sonja Adebahr, Michael Schultheiß, Dominik Bettinger, Ralph Fritsch, Volker Brass, (unknown), Hannes Neeff, Sven Arke Lang, Ursula Nestle, Anca-Ligia Grosu, Thomas Brunner	16
8	The role of albumin–bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy 2018 ·Strahlentherapie und Onkologie ·Eleni Gkika, Dominik Bettinger, (unknown), Michael Schultheiß, Hannes Neeff, (unknown), (unknown), Sonja Adebahr, Simon Kirste, Ursula Nestle, Robert Thimme, Anca-Ligia Grosu, Thomas Brunner	21
9	Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma 2017 ·BMC Cancer ·Eleni Gkika, (unknown), Simon Kirste, Sonja Adebahr, (unknown), Hannes Neeff, Ralph Fritsch, Volker Brass, Ursula Nestle, Anca-Ligia Grosu, Thomas Brunner	32
10	Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? 2017 ·PLoS ONE ·Eleni Gkika, Werner Vach, Sonja Adebahr, (unknown), (unknown), Thomas Brunner, Klaus Kaier, Antje Prasse, Joachim Müller‐Quernheim, Anca-Ligia Grosu, Gernot Zissel, Ursula Nestle	4
11	Interobserver variability in target volume delineation of hepatocellular carcinoma 2017 ·Strahlentherapie und Onkologie ·Eleni Gkika, Stephanie Tanadini‐Lang, Simon Kirste, Philipp Holzner, Hannes Neeff, Hans Christian Rischke, Thomas S. Reese, Fabian Lohaus, Marciana Nona Duma, Karin Dieckmann, R. Semrau, Marcus Stockinger, Detlef Imhoff, (unknown), Matthias Häfner, Nicolaus Andratschke, Ursula Nestle, Anca-Ligia Grosu, Matthias Gückenberger, Thomas Brunner	4
12	Desain Fasade Bangunan Tinggi Apartemen Dengan Aplikasi Panel Beton Pracetak 2016 ·(unknown), (unknown), (unknown), Thomas Brunner	1
13	The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells 2016 ·Radiotherapy and Oncology ·Osama Al‐Assar, Martin-Immanuel Bittner, Serena Lunardi, Michael R.L. Stratford, W. Gillies McKenna, Thomas Brunner	11
14	Kajian Manfaat Material Botol Bekas sebagai Elemen Dinding terhadap Kenyamanan Thermal & Visual Ditinjau dari Aspek Sustainable 2014 ·(unknown), (unknown), (unknown), (unknown), Thomas Brunner	2
15	The stromal compartments in pancreatic cancer: Are there any therapeutic targets? 2013 ·Cancer Letters ·Serena Lunardi, Ruth J. Muschel, Thomas Brunner	139
16	Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis \| Gemcitabin-basierte Strahlenchemotherapie beim lokal fortgeschrittenen Pankreaskarzinom - eine Metaanalyse 2012 ·Strahlentherapie und Onkologie ·Thomas Brunner	1
17	Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin Signaling 2011 ·Cancer Research ·Tine S. Mantoni, Serena Lunardi, Osama Al‐Assar, Atsushi Masamune, Thomas Brunner	170
18	Quality of Training in Radiation Oncology in Germany 2008 ·Strahlentherapie und Onkologie ·R. Semrau, (unknown), Markus Adam, Nicolaus Andratschke, Thomas Brunner, Frank Heinzelmann, Guido Hildebrandt, Dirk Vordermark, Daniel Zips	19
19	Ganzheitliches prozessorientiertes Projektmanagement 2004 ·Zeitschrift für wirtschaftlichen Fabrikbetrieb ·(unknown), Thomas Brunner, (unknown)	0
20	Tiefenverteilung und zeitliche Dynamik der mikrobiellen Biomasse in biologisch und konventionell bewirtschafteten Böden 1999 ·Organic Eprints (International Centre for Research in Organic Food Systems, and Research Institute of Organic Agriculture) ·Andreas Fließbach, D. Imhof, Thomas Brunner, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact